BMRN · Healthcare · $11.6B
After-hours $58.440.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 가장 큰 뉴스는 희귀질환 치료제 회사 아미쿠스(Amicus) 인수 완료예요.”
In the company's words · 2026 1분기 earnings call